维普中文期刊产品整合服务
10篇 您的检索式:作者名="Ravelli V"
    题名 作者 年代 出处 被引量
1Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals 显示文摘Mailer RH Runge S Ravelli V 2006Int J Pharm2006,317,1:1
2Dilated intercellular a spaces:a major morphological feature of esophagitis 显示文摘Ravelli AM Villanacci V Ruzzenenti N 2006J Pediatr Gastroenterol Nutr2006,42,5:1
3Cyclosporine-loaded solid lipid nanoparticles (SLN) : drug-lipid physicochemical interactions and characterization of drug incorporation 显示文摘Muler RH Runge SA Ravelli V 2008Eur JPharm Biopharm2008,68,3:1
4Oral bioavailability of cyclosporine: solid lipid nanoparticles (SLN) versus drug nanocrystals 显示文摘MULLER R H RUNGE S RAVELLI V 2006Int J Pharm2006,317,1:1
5Dietary protein-in- duced proctocolitis in childhood 显示文摘Ravelli A Villanacci V Chiappa S 2008Am J Gastroenterol2008,103,10:1
6Oral bioavail- ability of cyclosporine : solid lipid nanoparticles (SLN_) versus drug nanocrystals显示文摘MULLER R H RUNGE S RAVELLI V 2006lnt J Pharm2006,317,1:1
7Oral bioavailabilityof cyclosporine:solid lipid nanoparticles(SLN)versus drugnanocrystals显示文摘Müller RH Runge S Ravelli V 2006Int J Pharm2006,317,1:1
8Oral bioavailability of cy- closporine: Solid lipid nanoparticles( SLN~ ) versus drug nano- crystals 显示文摘Muller RH Runge S Ravelli V 2006Int J Pharm2006,317,:1
9Oral bioavailability of cy- closporine: solid lipid nanoparticles (SLN) versus drug nanoerys- tals显示文摘Muller RH Runge S Ravelli V 2006lnt J Pharm2006,317,1:1
10Oral bioavallability of cyclosporine: Solid lipid nanoparti- cles ( SLN) versus drug nanocrystals 显示文摘MULLER R H RUNGEA S RAVELLI V 2006Int J Pharm2006,317,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费